PMID: 8610654Apr 1, 1996Paper

Long-term follow-up of pathologic stage I large cell non-Hodgkin's lymphoma patients after primary radiotherapy

American Journal of Clinical Oncology
C K Lee, S H Levitt

Abstract

The purpose of this study was to examine the long-term outcome of Stage I large-cell non-Hodgkin's lymphoma patients treated with primary radiotherapy and to assess the potential influence of these results on the development of future treatment protocols for non-Hodgkin's lymphoma. Between April 1970 and July 1983, 15 pathological Stage I and four pathological Stage II large cell lymphoma patients were treated with primary radiotherapy at the University of Minnesota Hospital and Clinics. This paper focuses on the long-term outcome of the 15 Stage I patients. As of March 1995, with a median survival of 171 months, five of the 15 Stage I patients are alive: four with no sign of lymphoma and one with recurrence and a secondary malignant neoplasm (SMN). Estimated 5- and 10- year recurrence-free survival rates are 86% and 78%, respectively. Overall survival at 5 years is 80% and at 10 years, 67%. Six patients developed SMNs, all of which were solid tumors. Ten of the 15 patients died: four from SMNs, three from non-Hodgkin's lymphoma, and three from other causes without recurrence (two died of cardiovascular disease and one of a pulmonary embolism). Deaths due to lymphoma in pathologic Stage I patients treated by radiotherapy alone ...Continue Reading

References

May 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J K WeickH I Pierce
May 1, 1991·Hematological Oncology·M LishnerS Sutcliffe
Mar 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G CiminoD Giannarelli
Apr 1, 1991·Cancer·L B TravisJ F Fraumeni
Jan 1, 1991·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J M CossetM Tubiana
Sep 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S E JonesJ M Connors
Sep 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L LongoV T DeVita
Sep 1, 1988·International Journal of Radiation Oncology, Biology, Physics·B R PrestidgeR T Hoppe
Jun 15, 1988·Cancer·J F Boivin, K O'Brien
Jan 14, 1988·The New England Journal of Medicine·M A TuckerS A Rosenberg
Jan 1, 1985·Hematological Oncology·S H LevittG Frizzera
Oct 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E E VokesD Oleske
Nov 1, 1985·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S B SutcliffeM V Peters
Sep 1, 1973·Cancer·S E JonesS A Rosenberg
Feb 1, 1983·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A T SkarinE Frei
Feb 1, 1980·International Journal of Radiation Oncology, Biology, Physics·S MonfardiniA Lattuada

❮ Previous
Next ❯

Citations

Sep 2, 2020·Expert Review of Hematology·Emanuele CenciniMonica Bocchia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.